The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects*
Top Cited Papers
- 1 February 2006
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 34 (2) , 403-408
- https://doi.org/10.1097/01.ccm.0000198107.61493.5a
Abstract
To evaluate the effects of dobutamine on microcirculatory blood flow alterations in patients with septic shock. Prospective, open-label study. A 31-bed, medico-surgical intensive care unit of a university hospital. Twenty-two patients with septic shock. Intravenous administration of dobutamine (5 μg/kg·min) for 2 hrs (n = 22) followed by the addition of 10−2 M acetylcholine (topically applied, n = 10). Complete hemodynamic measurements were obtained before and after dobutamine administration. In addition, the sublingual microcirculation was investigated with an orthogonal polarization spectral imaging technique before and after dobutamine administration and after topical application of acetylcholine. Dobutamine significantly improved capillary perfusion (from 48 ± 15 to 67 ± 11%, p = .001), but with large individual variation, whereas capillary density remained stable. The addition of topical acetylcholine completely restored capillary perfusion (98 ± 1%, p = .001) and capillary density. The changes in capillary perfusion during dobutamine administration were not related to changes in cardiac index (p = .45) or arterial pressure (p = .29). Interestingly, the decrease in lactate levels was proportional to the improvement in capillary perfusion (y = 0.07 − 0.02x, r2 = .46, p = .005) but not to changes in cardiac index (p = .55). The administration of 5 μg/kg·min dobutamine can improve but not restore capillary perfusion in patients with septic shock. These changes are independent of changes in systemic hemodynamic variables.Keywords
This publication has 33 references indexed in Scilit:
- Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock*Critical Care Medicine, 2004
- Nitroglycerin for septic shockThe Lancet, 2003
- Bench-to-bedside review: Microvascular dysfunction in sepsis –hemodynamics, oxygen transport, and nitric oxideCritical Care, 2003
- Endothelin receptor antagonist bosentan improves microcirculatory blood flow in splanchnic organs in septic shockCritical Care Medicine, 2003
- Nitroglycerin in septic shock after intravascular volume resuscitationPublished by Elsevier ,2002
- Opening the microcirculation: can vasodilators be useful in sepsis?Intensive Care Medicine, 2002
- Microvascular Blood Flow Is Altered in Patients with SepsisAmerican Journal of Respiratory and Critical Care Medicine, 2002
- AMINOETHYL-ISOTHIOUREA INHIBITS THE INCREASE IN PLASMA ENDOTHELIN-1 CAUSED BY SEROGROUP A STREPTOCOCCI AND PROLONGS SURVIVAL IN RAT PERITONEAL SEPSISShock, 2001
- Effects of Nitric Oxide in Septic ShockAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Effects of Iloprost, a Stable Prostacyclin Analog, and Its Combination with Nω-Nitro-L-Arginine on Early Events following Lipopolysaccharide Injection: Observations in the Hamster Cheek Pouch MicrocirculationInternational Journal of Microcirculation, 1995